XAB2 and colorectal adenocarcinoma: The high expression of XAB2 was subsequently validated using data from unpaired and paired colorectal adenocarcinoma (COADREAD) cohorts in The Cancer Genome Atlas (TCGA) (Fig. 1B-C).